Streetbeat News

CRON

Cronos Group Inc.

https://www.thecronosgroup.com

Industry

Drug Manufacturers - Specialty & Generic

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Open

2.07

Mkt cap

768M

Volume

1.2M

High

2.10

P/E Ratio

-14.36

52-wk high

3.14

Low

2.01

Div yield

N/A

52-wk low

1.85

A new poll by the American Bankers Association (ABA) reveals that 63% of Americans support allowing marijuana businesses access to banking services. This comes as Congress sees a renewed push for the Secure and Fair Enforcement (SAFER) Banking Act, aimed at protecting banks serving state-licensed cannabis businesses from federal penalties. Senate Majority Leader Chuck Schumer and Senate Banking Committee Chairman Sherrod Brown have expressed high priority for passing the SAFER Banking Act, with bipartisan and bicameral talks being described as productive. The bill, which has faced delays due to disagreements over non-cannabis banking regulations, is gaining momentum with efforts to bring it to the Senate floor this year.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 2:18 pm

Esperion Therapeutics received FDA approval for new labels on NEXLETOL and NEXLIZET, boosting its shares by 12.7% in pre-market trading. Other stocks like Forge Global Holdings, Canopy Growth, Masimo Corporation, Cronos Group, Nuvation Bio, Tilray Brands, WK Kellogg, GoodRx Holdings, and Century Aluminum also saw pre-market gains due to various factors including legislative changes, business restructuring, and analyst upgrades.

Portfolio Pulse from Avi Kapoor

March 25, 2024 | 9:34 am

Cannabis stocks experienced significant movements on March 22, 2024, with notable gainers including Canopy Growth, Aurora Cannabis, and SNDL, among others. Losers included Belgravia Hartford Cap, Heritage Cannabis Holding, and Elixinol Wellness. The movements reflect the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on March 19, 2024, with notable gainers including Canopy Growth, Body and Mind, and Charlotte's Web Holdings, among others. Conversely, several companies faced declines, such as Item 9 Labs and Heritage Cannabis Holding. The fluctuations highlight the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

March 19, 2024 | 9:30 pm

Marijuana stocks experienced significant gains on a bullish Monday, with Greenlane Holdings leading the surge at 31.82% increase. Notable gainers include Heritage Cannabis, Canopy Growth, and Aurora Cannabis among others. Conversely, a few companies like Rocky Mountain High and Global Compliance faced declines.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on March 15, 2024, with notable gainers including CordovaCann, Global Hemp Group, and Canopy Growth, among others. Conversely, Australis Capital led the losers with a dramatic drop. The movements reflect varying investor sentiments and market dynamics within the cannabis sector.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 9:30 pm

DEA officials are reportedly at odds with the Biden administration over the push to reschedule marijuana from Schedule I to Schedule III, despite recommendations from the U.S. Health and Human Services (HHS). The DEA is concerned about the increased THC potency and questions the medical value of cannabis. The move to Schedule III would allow state cannabis businesses federal tax deductions and ease research barriers but wouldn't federally legalize marijuana. The timeline for the DEA's decision is uncertain, but it's expected to be completed this year. The Biden administration's cannabis policies have been positively received by the public, according to recent polls.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 5:21 pm

The article reports significant movements in the cannabis stock market on March 4, 2024, listing both gainers and losers. Notable gainers include AusCann Group Holdings with a 2300.00% increase and Elixinol Wellness with a 122.22% rise. On the losing end, GreenGro Technologies saw a 99.00% decrease. Major US-listed companies mentioned are 22nd Century Group, Neptune Wellness Solutions, Genetic Technologies, Canopy Growth, Cronos Group, Mexco Energy, and Aurora Cannabis.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 9:30 pm

Marijuana stocks experienced significant movement on a bullish Friday, with Green Growth Brands leading the gains at 1900.00% increase. Notable gainers include Cara Therapeutics, Corbus Pharmaceuticals, and Genetic Technologies. Conversely, Elixinol Wellness led the losers with a 37.93% decrease. Other notable losers include Heritage Cannabis Holding and Pharmadrug.

Portfolio Pulse from Benzinga Insights

March 01, 2024 | 9:30 pm

Marijuana stocks experienced significant movements on February 29, 2024, with notable gainers including Green Growth Brands, Indiva, and Target Group, among others. Conversely, several companies faced declines, such as Global Compliance, Nextleaf Solutions, and Heritage Cannabis Holding. Key stocks like Genetic Technologies, Greenlane Holdings, Scotts Miracle Gro, and GrowGeneration also saw upward movements, while Cronos Group and cbdMD were among the notable losers.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.